UsamaGergisMDMBA

PubMed

• Projected Impact of Omidubicel-onlv on Racial/Ethnic Disparities in Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) Outcomes in Hematologic Malignancies.
  Nandita Khera, Marie Louise Edwards, Yan Song, Rochelle Sun, Rocio Manghani, Heayoung Shin, Ronit Simantov, James Signorovitch, Smitha Sivaraman, Usama Gergis> ;Advances in Therapy. 2024 Apr 1
• Chimeric Antigen Receptor T - Cell Therapy for Large B-Cell Lymphoma Patients with Central Nervous System Involvement, a Systematic Review and Meta-analysis.
  Ghada Elgohary, Yang Yang, Mia Gergis, Dongni Yi, Usama Gergis> ;Clinical Lymphoma, Myeloma & Leukemia. 2024 Apr 1
• 1 citations
  Health care costs among patients with hematologic malignancies receiving allogeneic transplants: a US payer perspective.
  Richard T Maziarz, Usama Gergis, Marie Louise Edwards, Yan Song, Qing Liu, Annika Anderson, James Signorovitch, Rocio Manghani, Ronit Simantov, Heayoung Shin, Smitha S...> ;Blood Advances. 2024 Mar 12
• 2 citations
  Donor-Derived Malignancy and Transplantation Morbidity: Risks of Patient and Donor Genetics in Allogeneic Hematopoietic Stem Cell Transplantation.
  Lacey S Williams, Kirsten M Williams, Nancy Gillis, Kelly Bolton, Frederik Damm, Natalie T Deuitch, Nosha Farhadfar, Usama Gergis, Siobán B Keel, Fotios V Michelis, Sa...> ;Transplantation and Cellular Therapy. 2024 Mar 1
• Chimeric antigen receptor T-cell treatment patterns in relapsed or refractory large B-cell lymphoma.
  Roxanna Seyedin, Julia T Snider, Krithika Rajagopalan, Sally W Wade, Usama Gergis> ;Future Oncology. 2023 Jul 1
• 2 citations
  A simple prognostic system in patients with myelofibrosis undergoing allogeneic stem cell transplantation: a CIBMTR/EBMT analysis.
  Roni Tamari, Donal P McLornan, Kwang Woo Ahn, Noel Estrada-Merly, Juan Carlos Hernández-Boluda, Sergio Giralt, Jeanne Palmer, Robert Peter Gale, Zachariah DeFilipp, Da...> ;Blood Advances. 2023 Aug 8
• 1 citations
  Expert consensus on microtransplant for acute myeloid leukemia in elderly patients -report from the international microtransplant interest group.
  Huisheng Ai, Nelson J Chao, David A Rizzieri, Xiaojun Huang, Thomas R Spitzer, Jianxiang Wang, Mei Guo, Armand Keating, Elizabeth F Krakow, Didier Blaise, Jun Ma, Depe...> ;Heliyon. 2023 Apr 1
• 4 citations
  Endemic or regionally limited parasitic and fungal infections in haematopoietic stem-cell transplantation recipients: a Worldwide Network for Blood and Marrow Transpla...
  Abid, M. B., Ibrahim N Muhsen, Sebastian Galeano, Dietger Niederwieser, Mickey B C Koh, Per Ljungman, Clarisse M Machado, Mohamed A Kharfan-Dabaja, Rafael de la Camara...> ;The Lancet. Haematology. 2023 Apr 1
• 11 citations
  Impact of second primary malignancy post-autologous transplantation on outcomes of multiple myeloma: a CIBMTR analysis.
  Brittany Knick Ragon, Mithun Vinod Shah, Anita D'Souza, Noel Estrada-Merly, Lohith Gowda, Gemlyn George, Marcos de Lima, Shahrukh Hashmi, Mohamed A Kharfan-Dabaja, Nav...> ;Blood Advances. 2023 Jun 27
• The two-step approach to allogeneic hematopoietic stem cell transplantation.
  Sikemi Ibikunle, Dolores Grosso, Usama Gergis> ;Frontiers in Immunology. 2023 Jan 1
• Chimeric Antigen Receptor T Cell Therapy For Solid Tumors.
  Jingmei Hsu, Yang Yang, Mia Gergis, Xia Bi, Dongni Yi, Usama Gergis> ;Hematology/oncology and Stem Cell Therapy. 2022 Dec 15
• 2 citations
  Next-Generation Chimeric Antigen Receptor T-cells.
  Dongni Yi, Mia Gergis, Jingmei Hsu, Yang Yang, Xia Bi, Mahmoud Aljurf, Usama Gergis> ;Hematology/oncology and Stem Cell Therapy. 2022 Dec 15
• 2 citations
  Chimeric Antigen Receptor T-cell Therapies in Lymphoma Patients with Central Nervous System Involvement.
  Dongni Yi, Mia Gergis, Ghada Elgohary, Jingmei Hsu, Yang Yang, Xia Bi, Usama Gergis> ;Hematology/oncology and Stem Cell Therapy. 2022 Dec 15
• 3 citations
  Allogeneic Chimeric Antigen Receptor T Cells for Hematologic Malignancies.
  Yang Yang, Xia Bi, Mia Gergis, Dongni Yi, Jingmei Hsu, Usama Gergis> ;Hematology/oncology and Stem Cell Therapy. 2022 Dec 15
• 2 citations
  Chimeric Antigen Receptor T-cell Therapy for Acute Myeloid Leukemia.
  Xia Bi, Jingmei Hsu, Mia Gergis, Yang Yang, Dongni Yi, Usama Gergis> ;Hematology/oncology and Stem Cell Therapy. 2022 Dec 15
• 7 citations
  Engraftment syndrome after allogeneic stem cell transplantation: a systematic review and meta-analysis.
  Ghada ElGohary, Amir A Toor, Usama Gergis> ;Bone Marrow Transplantation. 2023 Jan 1
• A Prospective, Randomized Trial Examining the Use of G-CSF Versus No G-CSF in Patients Post-Autologous Transplantation.
  Dolores Grosso, Benjamin Leiby, Lindsay Wilde, Matthew Carabasi, Joanne Filicko-O'Hara, William O'Hara, John L Wagner, Gina Mateja, Onder Alpdogan, Adam Binder, Margar...> ;Transplantation and Cellular Therapy. 2022 Dec 1
• 1 citations
  The effect of hematopoietic stem cell transplantation on fertility and strategies for improvement.
  Brittany File, Mia Gergis, Usama Gergis> ;Bone Marrow Transplantation. 2022 Nov 1
• 2 citations
  Outcomes of two-step haploidentical allogeneic stem cell transplantation in elderly patients with hematologic malignancies.
  Xia Bi, Usama Gergis, John L Wagner, Matthew Carabasi, Joanne Filicko-O'Hara, William O'Hara, Thomas Klumpp, Pierluigi Porcu, Neal Flomenberg, Dolores Grosso> ;Bone Marrow Transplantation. 2022 Nov 1
• 1 citations
  Worldwide Network for Blood and Marrow Transplantation Special Article on Key Elements in Quality and Accreditation in Hematopoietic Stem Cell Transplantation and Cell...
  Amal Alseraihy, Eoin McGrath, Dietger Niederwieser, Christian Chabannon, Jeff Szer, Mohamad Mohty, Mohamed A Kharfan-Dabaja, Kim Orchard, Joseph Schwartz, Walid Rashee...> ;Transplantation and Cellular Therapy. 2022 Aug 1
• 5 citations
  Cost-Effectiveness of Chimeric Antigen Receptor T Cell Therapy in Patients with Relapsed or Refractory Large B Cell Lymphoma: No Impact of Site of Care.
  Alice Kate Cummings Joyner, Julia Thornton Snider, Sally West Wade, Si-Tien Wang, Marric G Buessing, Scott Johnson, Usama Gergis> ;Advances in Therapy. 2022 Aug 1
• 9 citations
  Noninfectious Pulmonary Toxicity after Allogeneic Hematopoietic Cell Transplantation.
  Sagar S Patel, Kwang Woo Ahn, Manoj Khanal, Caitrin Bupp, Mariam Allbee-Johnson, Navneet S Majhail, Betty K Hamilton, Seth J Rotz, Hasan Hashem, Amer Beitinjaneh, Hill...> ;Transplantation and Cellular Therapy. 2022 Jun 1
• Optimizing Utilization of Blood Products in the Hematologic Malignancy Clinic: Less Is More.
  Adam F Binder, Katy Loos, Alexander Xu, Alexis R Peedin, Usama Gergis, Julie Katz Karp, Lindsay Wilde> ;JCO Oncology Practice. 2022 Jun 1
• 9 citations
  The mutational landscape in chronic myelomonocytic leukemia and its impact on allogeneic hematopoietic cell transplantation outcomes: a Center for Blood and Marrow Tra...
  Matthew Mei, Raju Pillai, Soyoung Kim, Noel Estrada-Merly, Michelle Afkhami, Lixin Yang, Zhuo Meng, Muhammad Bilal Abid, Mahmoud Aljurf, Ulrike Bacher, Amer Beitinjane...> ;Haematologica. 2023 Jan 1
• 9 citations
  The impact of HLA donor-specific antibodies on engraftment and the evolving desensitization strategies.
  Brittany File, Yanping Huang, Alexis Peedin, Usama Gergis> ;Bone Marrow Transplantation. 2022 Apr 1
• Join now to see all

Journal Articles

• The Addition Of Low Dose Total Body Irradiation To Fludarabine And Melphalan Conditioning In Haplo-Cord Transplantation For High Risk Hematological Malignancies  
  Choe HK, Gergis U, Mayer SA, Nagar H, Phillips AA, Shore TB, Smith MJ, van Besien K, Transplantation, 1/19/2016
• Reduced intensity haplo plus single cord transplant compared to double cord transplant: improved engraftment and survival free of progression and GVHD (GRFS)  
  Van Besien K, Hari P, Zhang MJ, Liu HT, Stock W, Godley L, Odenike O, Larson R, Bishop M, Wickrema A, Gergis U, Mayer S, Shore T, Tsai S, Rhodes J, Cushing MM, Korman ..., Haematologica, 1/11/2016
• Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Myelofibrosis with Prior Exposure to Janus Kinase 1/2 Inhibitors  
  Shanavas M, Popat U, Michaelis LC, Fauble V, McLornan D, Klisovic R, Mascarenhas J, Tamari R, Arcasoy MO, Davies J, Gergis U, Ukaegbu OC, Kamble RT, Storring JM, Majha..., Biol Blood Marrow Transplant, 1/1/2016
• Comparison of Subcutaneous versus Intravenous Alemtuzumab for Graft-versus-Host Disease Prophylaxis with Fludarabine/Melphalan-Based Conditioning in Matched Unrelated ...  
  Patel K, Parmar S, Shah S, Shore T, Gergis U, Mayer S, van Besien K, Biol Blood Marrow Transplant, 1/1/2016
• Cord blood chimerism and relapse after haplo-cord transplantation  
  van Besien K, Koshy N, Gergis U, Mayer S, Cushing M, Rennert H, Reich-Slotky R, Mark T, Pearse R, Rossi A, Phillips A, Vasovic L, Ferrante R, Hsu YM, Shore T, Leuk Lymphoma, 1/1/2016
• Spleen histology in myelofibrosis patients after hematopoietic stem cell transplant: a morphological and immunohistochemical study  
  Marco Pizzi, Usama Gergis, Felicia Chaviano, Attilio Orazi, Hematol Oncol Stem Cell Ther, 1/1/2016
• Cushing Engraftment for CD34 Selected Stem Cell Products is not compromised by Cryopreservation  
  Ronit Reich-Slotky, Lohith S. Bachegowda, Michael Ancharski, Usama Gergis, Koen van-Besien and Melissa M, Transfusion, 1/12/2015
• Impact of Prophylactic Levofloxacin on Rates of Bloodstream Infection and Fever in Neutropenic Patients with Multiple Myeloma Undergoing Autologous Hematopoietic Stem ...  
  Satlin MJ, Vardhana S, Soave R, Shore TB, Mark TM, Jacobs SE, Walsh TJ, Gergis U, Biol Blood Marrow Transplant, 1/1/2015
• Effect of postremission therapy before reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia in first complete remission  
  Warlick ED, Paulson K, Brazauskas R, Zhong X, Miller AM, Camitta BM, George B, Savani BN, Ustun C, Marks DI, Waller EK, Baron F, Freytes CO, Socie G, Akpek G, Schouten..., Biol Blood Marrow Transplant, 1/1/2014
• A strategy to reduce donor-specific HLA Abs before allogeneic transplantation  
  Gergis U, Mayer S, Gordon B, Mark T, Pearse R, Shore T, Van Besien K, Bone Marrow Transplant, 1/1/2014
• Autologous stem cell transplant in human immunodeficiency virus-positive patients with lymphoid malignancies: focus on infectious complications Leuk Lymphoma  
  Morawa E, Martin P, Gergis U., van Besien K, Shore T, Leuk Lymphoma, 1/1/2013
• A Phase 1 Study of Bendamustine and Melphalan Conditioning for Autologous Stem Cell Transplantation in Multiple Myeloma  
  Tomer M. Mark MD, MSc, Whitney Reid, Ruben Niesvizky MD, Usama Gergis MD, Roger Pearse MD,PhD, Sebastian Mayer MD, June Greenberg RN, Morton Coleman MD, Koen Van Be..., Biol Blood Marrow Transplant, 1/1/2013
• A phase I study of CPX-351 in combination with Busulfan and Fludarabine conditioning and allogeneic stem cell transplantation in adult patients with refractory acute l...  
  Usama Gergis, MD, Gail Roboz, MD , Tsiporah Shore, MD , Ellen Ritchie, MD, Sebastian Mayer, MD, Usama Wissa, MD, Marshall McKenna, Paul Christos, DrPH, Roger Pearse,..., Biol Blood Marrow Transplant, 1/1/2013
• Current status of allogeneic HST for chronic myelomonocytic leukemia  
  Cheng H, Kirtani VG, Gergis U, Bone Marrow Transplant, 1/1/2012
• Join now to see all

Books/Book Chapters

• Maternal Health 
  Chapter: Hematologic Malignancies in Pregnancy 
  Page 513 - 534Usama Gergis, Pinkal Desai, Adriana Rossi, Adrienne PhillipsEditors: Juise D. Pacheco, George R. Saade and Gary D.V. Hankins.McGraw Hill2015

Abstracts/Posters

• Disease Risk Index (DRI) and Age but Not HCT Comorbidity Index (HCT-CI) Are Predictive of Overall Survival after Cord Blood Transplantation Supported By Haplo-CD34+ pr...
  Usama Gergis, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Thirty-Day Transfusion and G-CSF Requirement after CD19 CAR T Infusion
  Usama Gergis, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Haplo-Cord Transplantation with Anti-Thymocyte Globulin: Comparative Clinical Outcomes with or without Routine G-CSF Administration
  Usama Gergis, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

• Does Presence of Persistent Molecular Mutations Matter in AML Patients Undergoing Allogeneic Stem Cell Transplant? 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Hematopoietic Stem Cell Transplant in Novel Agent Era Is Associated with Improved Survival in Relapsed and Refractory Peripheral T-Cell Lymphoma 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• CCR5 delta32 Cord & Haploidentical Grafts: Allogeneic Stem Cell Transplant for HIV+ /AML Patient: A Case Report from the Impaact P1107 Observational StudyClinically Re... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Long term complications of bone marrow transplantation 
  King Faisal Research and Cancer Center, Riyadh, Saudi Arabia - 1/17/2017
• Cell Processing and HLA Typing 
  King Faisal Research and Cancer Center, Riyadh, Saudi Arabia - 1/15/2017
• Targeting the JAK Pathway in Patients Whose Polycythemia Vera 
  112 E 83rd St, New York, NY 10028 - 1/12/2016
• Defining uncontrolled Polycythemia Vera 
  Metropolitan Hospital, 1902 First Avenue, NY, NY 10029 - 1/8/2016
• The risk of invasive fungal infections in neutropenia and GVHD 
  Robert Wood Johnson University Hospital, New Brunswick, NJ - 1/2/2016
• PNH Regional Patient Meeting 
  Teaneck Marriott at Glenpointe, Teaneck, NJ, 2015; Intercontinental Hotel, New Orleans, LA, 2016 - 1/1/2016
• Understanding testing and monitoring for CML 
  Good Samaritan Hospital, Dayton, OH - 1/30/2015
• Antifungal prophylaxis in prolonged neutropenia 
  Brooklyn, NY, 2015; Beth Israel Deaconess Medical Center, Plymouth, MA, 2015 - 1/21/2015
• Pathophysiology of Polythysemis Vera 
  West Columbia, SC - 1/20/2015
• NORD Patient Meeting for Paroxysmal Nocturnal Hemoglobinuria 
  Brown Palace Hotel, Denver, CO - 1/16/2015
• Pathophysiology of aHUS 
  WDW Dolphin Hotel, Orlando, FL, 2015; Promise Hospital of Salt Lake, Salt Lake City, UT, 2015 - 1/14/2015
• Antifungal prophylaxis in prolonged neutropenia and GVHD 
  Indiana University, Indianapolis, IN - 1/13/2015
• Treatment of Ph+ CML in Chronic Phase 
  Jacksonville, FL - 1/3/2015
• Prognostic factors in MDS 
  1/24/2014
• Invasive Fungal Infection prophylaxis in patients with acute GVHD 
  Brooke Army Medical Center, San Antonio, TX - 1/24/2014
• Antifungal prophylaxi in acute GVHD 
  Tufts Medical Center, Boston, MA - 1/20/2014
• Pathophysiology of PNH 
  Dubai Hospital, UAE - 1/19/2014
• Cytogenetic Abnormalities in MDS 
  Brookdale University Hospital, Brooklyn, NY - 1/9/2014
• Refractory Leukemia, chemotherapy or transplant? 
  Hackensack Cancer Center, Hackensack, NJ - 1/11/2013
• Umbilical Cord Transplantation 
  Staten Island University Hospital, Staten Island, NY - 1/9/2013
• Refractory AML, can we do better? 
  Nassau County Hospital, Long Island, NY - 1/1/2013
• Umbilical cord blood transplantation 
  The Brooklyn Hospital Center, Brooklyn, NY - 1/1/2012
• Join now to see all